Picture of Kalvista Pharmaceuticals logo

KALV — Kalvista Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Brief: Kalvista Pharmaceuticals Q4 Net Income USD -44.65 Million

Jul 11 (Reuters) - Kalvista Pharmaceuticals Q4 operating expenses USD 48.455
million.
* Q4 operating income USD -48.455 million
* Q4 basic EPS USD -1.02

Recent news on Kalvista Pharmaceuticals

See all news